Larger Than Life Science
Join us for beer, demos and panel discussions this Apr 25th from 4-7pm at LaunchBio’s “Larger Than Life Science” event at BioLabs new Towne Center facility.
Larger Than Life Science Read More »
Join us for beer, demos and panel discussions this Apr 25th from 4-7pm at LaunchBio’s “Larger Than Life Science” event at BioLabs new Towne Center facility.
Larger Than Life Science Read More »
In December, we launched Pharm2Market, a new business intelligence platform for biotech communities. The San Diego database has profiles for over 250 local drug discovery companies, over a dozen local investors, and 110 resource companies that provide everything from reagents to real estate services. In this presentation, we take a look behind those numbers to
San Diego By The Numbers Read More »
We take a look at the San Francisco drug discovery community and the stats behind the business development, investment, and partnering opportunities.
San Francisco By The Numbers Read More »
The new year has begun, and with it the search for new customers. We spoke with local biotech business development professionals to learn more about the detective-work they do to find new customers. Here’s what we learned.
Pharm2Market – Watching The Detectives Read More »
Starting a biotech company is challenging at the best of times. In her book “How To Start A Life Science Company”, Dr Leah Cannon describes some of the business challenges that biotech companies face: the attrition rates for drugs remain high, the regulatory requirements are continuing to grow, and finding the right investors and partners
Pharm2Market – Connecting The Life Science Community Read More »
Every company you work for teaches you lessons. Early on in my career, I worked for a global oil & gas company. Agility isn’t typically a word one normally associates with global companies, but this was different. This was agility on a global scale. There are often cases where you need to analyze a large
In a couple of recent posts I wrote about the current landscape of life science podcasts, and highlighted some of the consistently highest rated ones, and some of the podcasts that deserve a second look. One thing has become readily apparent though, is that even with the variety of podcasts currently available, there are a
Missed Opportunities in Life Science Podcasts Read More »
During the course of evaluating the podcasts, I came across a number of issues that podcasters were running into. Issues that can make the difference between attracting the right target audience, or driving them away
Mistakes Life Science Podcasters Make Read More »
Some interesting new features in Cytoscape, the open source biological network analysis application.
Tinkering with the Latest Cytoscape Release Read More »
A few years ago, Luke Timmerman of Xconomy wrote about the 21 Red Flags in biotech investing and Sally Church of the Pharmastrategy Blog wrote a related post on Red Flags in clinical trials and cancer research. Here are a few additions of my own that I’d like to add to those lists. Context is
Red Flags in Drug Discovery Read More »